Cargando…

Guideline Adherence As An Indicator of the Extent of Antithrombotic Overuse and Underuse: A Systematic Review

Thromboembolic events are a common risk in adults with atrial fibrillation, those with previous cerebrovascular accidents and undergoing emergency or elective surgeries. The widespread availability of antithrombotic agents and differing guidelines contribute to practice variations and increased risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardona, Magnolia, Craig, Louise, Jones, Mark, Byambasuren, Oyungerel, Obucina, Mila, Hattingh, Laetitia, Clark, Justin, Glasziou, Paul, Hoffmann, Tammy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ubiquity Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374022/
https://www.ncbi.nlm.nih.gov/pubmed/36051325
http://dx.doi.org/10.5334/gh.1142
_version_ 1784767707828191232
author Cardona, Magnolia
Craig, Louise
Jones, Mark
Byambasuren, Oyungerel
Obucina, Mila
Hattingh, Laetitia
Clark, Justin
Glasziou, Paul
Hoffmann, Tammy
author_facet Cardona, Magnolia
Craig, Louise
Jones, Mark
Byambasuren, Oyungerel
Obucina, Mila
Hattingh, Laetitia
Clark, Justin
Glasziou, Paul
Hoffmann, Tammy
author_sort Cardona, Magnolia
collection PubMed
description Thromboembolic events are a common risk in adults with atrial fibrillation, those with previous cerebrovascular accidents and undergoing emergency or elective surgeries. The widespread availability of antithrombotic agents and differing guidelines contribute to practice variations and increased risk of complications and deaths. The objective of this review was to investigate the extent of overuse and underuse of antithrombotics for primary or secondary prevention as measured by deviation from prescribing guideline recommendations. We conducted a systematic review of Medline and EMBASE for quantitative articles published between 2000 and 2021 and used a modified version of the Hoy’s risk of bias assessment tool. Here we report evidence from the past decade about wide practice variations in hospitals and primary care, and discuss clinician and patient-driven determinants of non-adherence to guidelines. Finally, we summarise implications for practice, identify enhanced ways of measuring overuse and underuse, and propose potential solutions to the measurement challenges.
format Online
Article
Text
id pubmed-9374022
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Ubiquity Press
record_format MEDLINE/PubMed
spelling pubmed-93740222022-08-31 Guideline Adherence As An Indicator of the Extent of Antithrombotic Overuse and Underuse: A Systematic Review Cardona, Magnolia Craig, Louise Jones, Mark Byambasuren, Oyungerel Obucina, Mila Hattingh, Laetitia Clark, Justin Glasziou, Paul Hoffmann, Tammy Glob Heart Review Thromboembolic events are a common risk in adults with atrial fibrillation, those with previous cerebrovascular accidents and undergoing emergency or elective surgeries. The widespread availability of antithrombotic agents and differing guidelines contribute to practice variations and increased risk of complications and deaths. The objective of this review was to investigate the extent of overuse and underuse of antithrombotics for primary or secondary prevention as measured by deviation from prescribing guideline recommendations. We conducted a systematic review of Medline and EMBASE for quantitative articles published between 2000 and 2021 and used a modified version of the Hoy’s risk of bias assessment tool. Here we report evidence from the past decade about wide practice variations in hospitals and primary care, and discuss clinician and patient-driven determinants of non-adherence to guidelines. Finally, we summarise implications for practice, identify enhanced ways of measuring overuse and underuse, and propose potential solutions to the measurement challenges. Ubiquity Press 2022-08-12 /pmc/articles/PMC9374022/ /pubmed/36051325 http://dx.doi.org/10.5334/gh.1142 Text en Copyright: © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC-BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. See http://creativecommons.org/licenses/by/4.0/.
spellingShingle Review
Cardona, Magnolia
Craig, Louise
Jones, Mark
Byambasuren, Oyungerel
Obucina, Mila
Hattingh, Laetitia
Clark, Justin
Glasziou, Paul
Hoffmann, Tammy
Guideline Adherence As An Indicator of the Extent of Antithrombotic Overuse and Underuse: A Systematic Review
title Guideline Adherence As An Indicator of the Extent of Antithrombotic Overuse and Underuse: A Systematic Review
title_full Guideline Adherence As An Indicator of the Extent of Antithrombotic Overuse and Underuse: A Systematic Review
title_fullStr Guideline Adherence As An Indicator of the Extent of Antithrombotic Overuse and Underuse: A Systematic Review
title_full_unstemmed Guideline Adherence As An Indicator of the Extent of Antithrombotic Overuse and Underuse: A Systematic Review
title_short Guideline Adherence As An Indicator of the Extent of Antithrombotic Overuse and Underuse: A Systematic Review
title_sort guideline adherence as an indicator of the extent of antithrombotic overuse and underuse: a systematic review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9374022/
https://www.ncbi.nlm.nih.gov/pubmed/36051325
http://dx.doi.org/10.5334/gh.1142
work_keys_str_mv AT cardonamagnolia guidelineadherenceasanindicatoroftheextentofantithromboticoveruseandunderuseasystematicreview
AT craiglouise guidelineadherenceasanindicatoroftheextentofantithromboticoveruseandunderuseasystematicreview
AT jonesmark guidelineadherenceasanindicatoroftheextentofantithromboticoveruseandunderuseasystematicreview
AT byambasurenoyungerel guidelineadherenceasanindicatoroftheextentofantithromboticoveruseandunderuseasystematicreview
AT obucinamila guidelineadherenceasanindicatoroftheextentofantithromboticoveruseandunderuseasystematicreview
AT hattinghlaetitia guidelineadherenceasanindicatoroftheextentofantithromboticoveruseandunderuseasystematicreview
AT clarkjustin guidelineadherenceasanindicatoroftheextentofantithromboticoveruseandunderuseasystematicreview
AT glaszioupaul guidelineadherenceasanindicatoroftheextentofantithromboticoveruseandunderuseasystematicreview
AT hoffmanntammy guidelineadherenceasanindicatoroftheextentofantithromboticoveruseandunderuseasystematicreview